Page last updated: 2024-10-17

2-aminoadipic acid and Infant, Newborn, Diseases

2-aminoadipic acid has been researched along with Infant, Newborn, Diseases in 1 studies

2-Aminoadipic Acid: A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
2-aminoadipic acid : An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine.

Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gray, RG1
O'Neill, EM1
Pollitt, RJ1

Other Studies

1 other study available for 2-aminoadipic acid and Infant, Newborn, Diseases

ArticleYear
Alpha-aminoadipic aciduria: chemical and enzymatic studies.
    Journal of inherited metabolic disease, 1980, Volume: 2, Issue:4

    Topics: 2-Aminoadipic Acid; Amino Acid Metabolism, Inborn Errors; Amino Acids; Amino Acids, Dicarboxylic; Fe

1980